Delivery Order SPE2DB22D2005-SPE2DB24FJEU9
Award Date 11/20/23
Potential Completion Date 11/21/23
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,555.09, is for the delivery of 4567678075 ! DROXIDOPA 100 MG CAPSULE 90S. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $34,442.65 to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Droxidopa 100 mg capsules (90-count units). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,586.62 firm fixed-price contract is for the delivery of 4,564,640,389 units of the drug Droxidopa 100 mg capsules. The contract has a completion date of May 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY8J9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,008.41 firm fixed-price delivery order contract is for the supply of 4566929688 - DROXIDOPA 300 MG CAPSULE 90S. The ultimate completion date for this contract is January 15, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Department of Defense Medical Supply Chain on September 29, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) valued at $26,921.20. This award is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $67,481 for the supply of Droxidopa 100 mg capsules (90-count units). The contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and was not designated as a set-aside procurement. This delivery order represents a single requisition fulfilled under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,550.83 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a range of pharmaceutical products and medical supplies. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle. The contract allows for multiple...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Droxia 300 mg capsules (60-count units) with a firm fixed price of $1,507.20 and a completion date of December 9, 2025. This non-set-aside competitive award is classified as a delivery order, indicating it derives from a larger contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,583.68 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a range of medical products and supplies to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing essential pharmaceuticals, medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $70,361.94 contract is for the supply of a variety of medical and pharmaceutical products, including prescription medications, medical devices, and healthcare commodities, to support the agency's medical supply chain requirements. This delivery order is part of a larger $999,999,999.00...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJEU9Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The delivery order has a period of performance through November 21, 2023.
Generated 5/12/25, 10:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 11/20/23 |